What is NDC 51662-1523?

51662-1523 is the product NDC for THIAMINE HCl, Thiamine hydrochloride 100 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for THIAMINE HCl?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

THIAMINE HCl NDC 51662-1523 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1523Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1523Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1523-1	5166215230151662152301	2 mL in 1 VIAL, MULTI-DOSE (51662-1523-1)Marketed from Jun 14, 2021
51662-1523-3	5166215230351662152303	25 POUCH in 1 CASE (51662-1523-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1523-2) / 2 mL in 1 VIAL, MULTI-DOSEMarketed from Nov 10, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): THIAMINE HCl
Generic name (nonproprietary): thiamine hcl
Active ingredients: Thiamine hydrochloride — 100 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 080556
Marketing start: Jun 14, 2021
Listing expires: Dec 31, 2026
Identifiers: Product ID 51662-1523_101e59b2-b8c3-3079-e063-6294a90a0a80SPL ID 101e59b2-b8c3-3079-e063-6294a90a0a80SPL set ID c4c436ab-cbb7-9429-e053-2995a90a58aeRxCUI 313324UNII M572600E5PUPC 0363323013011

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662152301 followed by a unit qualifier and the quantity

Package 51662-1523-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2024.

Indications (excerpt from the label)

INDICATIONS Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. Thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in Wernicke’s encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. It is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. Thiamine hydrochloride injection is also indicated i…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1523

What is NDC 51662-1523?: 51662-1523 is the product NDC for THIAMINE HCl, Thiamine hydrochloride 100 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: THIAMINE HCl.
What is the active ingredient?: Thiamine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for THIAMINE HCl?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 080556

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 080556
Product	Strength	Form · route	Labeler	Product NDC
Thiaminethiamine hydrochloride	Thiamine hydrochloride 100 mg/mL	Injection, SolutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-013